SCHEMBL322499

SCHEMBL322499

CCCCCCCCCCCCCCCCCCC(CCCCCCCCCCCCCCCCCC)CC(N)N(CCO)CCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
CYP2D6 P10635 2/20 0.41
SPHK1 Q9NYA1 2/20 0.41
TP53 P04637 2/20 0.41
PLA2G1B P04054 1/20 0.41
PLA2G2A P14555 1/20 0.41
GMNN O75496 1/20 0.41
POLB P06746 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41
BLM P54132 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
CETP P11597 1/20 0.41
HTT P42858 1/20 0.41
UBE2N P61088 1/20 0.41
LAP3 P28838 1/20 0.37
GRIK1 P39086 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL30801645 0.81 LMNA (0.42) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL27528570 0.77 ALDH1A1 (0.37) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL10705706 0.75 LMNA (0.48) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL10873422 0.74 SPHK1 (0.44) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL24784722 0.74 LMNA (0.46) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL9486070 0.74 LMNA (0.46) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL20661573 0.74 LMNA (0.46) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL1243039 0.74 LMNA (0.46) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL9651718 0.74 LMNA (0.46) LMNACYP2D6SPHK1TP53PLA2G1B
SCHEMBL29635020 0.73 TSHR (0.33) MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630175-A1 METHODS AND DEVICES FOR THE TREATMENT OF FOOD ALLERGIES Texas Tech University System (US) 2020-04-08 EP claimed
WO-2018222874-A1 METHODS AND DEVICES FOR THE TREATMENT OF FOOD ALLERGIES TEXAS TECH UNIVERSITY SYSTEM (US) 2018-12-06 WO claimed
US-20070065457-A1 Circovirus sequences associated with piglet weight loss disease (PWD) WYETH 2007-03-22 US claimed
EP-4138894-A1 COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND DIAGNOSING MYCOBACTERIAL INFECTIONS The University of Saskatchewan (CA) 2023-03-01 EP disclosed
EP-3931332-A1 LAWSONIA INTRACELLULARIS COMPOSITIONS AND METHODS OF USING THE SAME The University of Saskatchewan (CA) 2022-01-05 EP disclosed
WO-2021212215-A1 COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND DIAGNOSING MYCOBACTERIAL INFECTIONS UNIVERSITY OF SASKATCHEWAN (CA) 2021-10-28 WO disclosed
EP-3630175-A1 METHODS AND DEVICES FOR THE TREATMENT OF FOOD ALLERGIES Texas Tech University System (US) 2020-04-08 EP disclosed
EP-3554536-A1 RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS, AND VACCINES COMPRISING THEM Boehringer Ingelheim Animal Health USA Inc. (US) 2019-10-23 EP disclosed
EP-3528842-A1 RECOMBINANT VECTORS EXPRESSING ANTIGENS OF AVIAN INFLUENZA VIRUS AND USES THEREOF Boehringer Ingelheim Animal Health USA Inc. (US) 2019-08-28 EP disclosed
WO-2018222874-A1 METHODS AND DEVICES FOR THE TREATMENT OF FOOD ALLERGIES TEXAS TECH UNIVERSITY SYSTEM (US) 2018-12-06 WO disclosed
WO-2018112051-A1 RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS, AND VACCINES COMPRISING THEM MERIAL, INC. (US) 2018-06-21 WO disclosed
EP-1465639-A4 ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME IRX THERAPEUTICS INC (US) 2006-05-24 EP disclosed
WO-2005076001-A2 A POLYPEPTIDE DERIVED FROM GP41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2005-08-18 WO disclosed
EP-1490101-A1 METHODS OF ENHANCING IMMUNE INDUCTION INVOLVING MDA-7 BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) 2004-12-29 EP disclosed
EP-1465639-A2 ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME Immuno-RX, Inc. (US) 2004-10-13 EP disclosed
WO-2004033665-A9 HETEROLOGOUS PLASMA COCKTAIL FOR HIV TREATMENT IMUTEX PHARMACEUTICALS INC (US) 2004-05-27 WO disclosed
EP-1418940-A2 DNA EXPRESSION VECTORS AND METHODS OF USE Emory University (US) 2004-05-19 EP disclosed
WO-2003075952-A1 METHODS OF ENHANCING IMMUNE INDUCTION INVOLVING MDA-7 BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2003-09-18 WO disclosed
WO-2003049670-A2 ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME IMMUNO-RX, INC. (US) 2003-06-19 WO disclosed
WO-2001092470-A2 DNA EXPRESSION VECTORS AND METHODS OF USE EMORY UNIVERSITY (US) 2001-12-06 WO disclosed